PRESS RELEASE published on 11/06/2025 at 22:15, 5 months 25 days ago Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 Revelation Biosciences, Inc. reports financial results for Q3 2025 and highlights milestone achievements in clinical study and fundraising, focusing on rebalancing inflammation for health optimization Financial Results Clinical Study Inflammation Revelation Biosciences Health Optimization
PRESS RELEASE published on 11/06/2025 at 22:05, 5 months 25 days ago Innodata Announces New Leadership Appointments to Support Next Phase of Growth Innodata Inc. announces executive management & Board appointments to support rapid growth in generative AI solutions. Rahul Singhal appointed President & CRO, Daniel Callahan & Richard Clarke to Board, Jack Abuhoff as Chairman, Stewart Massey as Lead Independent Director. Third Quarter 2025 results released Executive Management Innodata Inc. Board Appointments Generative AI Solutions Third Quarter 2025 Results
PRESS RELEASE published on 11/06/2025 at 22:05, 5 months 25 days ago ShelfieTech Ltd. Announces Private Placement of up to $2 Million ShelfieTech Ltd. announces a non-brokered private placement of up to $2 million for corporate purposes, R&D, acquisitions, and working capital. The Offering is subject to regulatory approvals Private Placement Common Shares Non-brokered Technological Solutions ShelfieTech Ltd.
PRESS RELEASE published on 11/06/2025 at 22:05, 5 months 25 days ago Unusual Machines Issues Letter to Shareholders Unusual Machines, Inc. CEO Allan Evans shares Q3 2025 highlights and strategic insights in a letter to shareholders. The company reported record revenue, profitability, and strong cash position for continued growth Record Revenue Strategic Insights Unusual Machines Inc. Q3 2025 Allan Evans
PRESS RELEASE published on 11/06/2025 at 22:05, 5 months 25 days ago Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update Protagonist Therapeutics reports financial results and updates on NDA submissions for icotrokinra and rusfertide, as well as progress in clinical trials for PN-881 and IND-enabling studies for PN-477sc and PN-477o Financial Results Clinical Trials Protagonist Therapeutics IND-enabling Studies NDA Submissions
REGULATED PRESS RELEASE published on 11/06/2025 at 22:00, 5 months 25 days ago Fusion absorption de la société française Interparfums Holding SAS par la société Interparfums SA Fusion absorption d'Interparfums Holding SAS par Interparfums SA sans offre publique de retrait. Assemblée générale extraordinaire le 17 décembre 2025 AMF Paris Assemblée Générale Interparfums Fusion Absorption
REGULATED PRESS RELEASE published on 11/06/2025 at 22:00, 5 months 25 days ago Merger by absorption of the French company Interparfums Holding SAS by the French company Interparfums SA French company Interparfums SA plans merger by absorption with Interparfums Holding SAS. AMF decides no public offer needed, General Meeting on December 17, 2025, details available online Shareholders Merger AMF Interparfums General Meeting
PRESS RELEASE published on 11/06/2025 at 21:30, 5 months 25 days ago ACQUISITION DE 97,68% DE LA SOCIÉTÉ DE TAYNINH SUIVIE D'UNE OFFRE PUBLIQUE D'ACHAT SIMPLIFIÉE (SANS INTENTION DE RETRAIT OBLIGATOIRE) AU PRIX DE 0,11EUR PAR ACTION Unibail-Rodamco-Westfield cède sa participation dans Société de Tayninh à trois investisseurs. Projet d'offre publique d'achat à venir Cession Offre Publique D'achat Investisseurs Participation Unibail-Rodamco-Westfield
PRESS RELEASE published on 11/06/2025 at 19:55, 5 months 25 days ago EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for financial year 2025 Pentixapharm Holding AG significantly reduces projected loss for financial year 2025 due to clinical development program realignment Clinical Development Realignment Pentixapharm Financial Year 2025 Projected Loss
PRESS RELEASE published on 11/06/2025 at 19:05, 5 months 25 days ago Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement Cell Impact and thyssenkrupp Automation Engineering enter Strategic Cooperation Agreement for Joint Market Success in Hydrogen field, focusing on flow plates and manufacturing processes for fuel cells and electrolyzers Fuel Cells Hydrogen Thyssenkrupp Cell Impact Strategic Cooperation Agreement
Published on 05/02/2026 at 01:30, 9 hours 54 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 10 hours 34 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 11 hours 24 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 11 hours 24 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 12 hours 54 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 17:45, 17 hours 38 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:45, 17 hours 38 minutes ago Le Groupe Burkhalter rachète Progressio Holding GmbH et anplaq ag, Tamins (GR)
Published on 04/30/2026 at 21:21, 1 day 14 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 1 day 15 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 1 day 15 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 1 day 16 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 1 day 16 hours ago AXA annonce les résultats de son Assemblée Générale